Skip to Content
Søk Menu

MEDtalks

Senaste MEDtalk

Malin Rasmussen

EHA 2025: Radiotherapy in FL Linked to Low Relapse Rates

/ Malin Rasmussen
EHA25Lymfom Play the Video
Christoffer Vannas

Swedish Insights Into Alpelisib Treatment for Metastatic Breast Cancer with PIK3CA Mutation

/ Christoffer Vannas
BröstcancerNBCN Play the Video

Carl Sandén

EHA 2025: Novel Immune Escape Pathway in AML Identified and Successfully Blocked

/ Carl Sandén
AMLEHA25 Play the Video
Sara Rossetti

EHA 2025: Tripled Cardiac Morbidity Risk After Hodgkin Lymphoma Therapy

/ Sara Rossetti
EHA25Hodgkins lymfom Play the Video
Malene Grubbe Hildebrandt

The Fascinating World of Using Molecular Imaging in Primary and Metastatic Breast Cancer

/ Malene Grubbe Hildebrandt
BröstcancerNBCN Play the Video
Justinas Daraskevicius

EHA 2025: Overcoming Venetoclax Resistance

/ Justinas Daraskevicius
EHA25 Play the Video

New Finnish Study Investigates Outcomes of Repeated Breast Conserving Surgery and Radiotherapy

/ Anselm Tamminen
BröstcancerNBCN Play the Video
Lydia Scarfò

EHA 2025: First-in-Class BTK Degrader Drives Strong Responses in R/R CLL/SLL

/ Lydia Scarfò
CLLEHA25 Play the Video
Anna Sundholm

NDPH: Understanding A Rare Chronic Headache

/ Anna Sundholm
Huvudvärk Play the Video
Henrik Frederiksen

EHA 2025: ADHD Treatment medication alleviate Fatigue in Patients with Malignant Diseases show Danish Study

/ Henrik Frederiksen
EHA25 Play the Video
Sara Tolaney

ASCO 2025: Redefining First-Line Therapy in HER2+ Breast Cancer with T-DXd and Pertuzumab

/ Sara Tolaney
ASCO25BröstcancerNBCN Play the Video
Katarina Holmberg

Symptom Burden and Self-Care Challenges in Hematopoietic Cell Transplantation

/ Katarina Holmberg
Play the Video
Mats Jerkeman

Several Options for Frontline Treatment of MCL

/ Mats Jerkeman
EHA25Lymfom Play the Video
Paolo Ghia

EHA 2025: Durable Undetectable MRD Responses with Acalabrutinib in CLL

/ Paolo Ghia
CLLEHA25 Play the Video
Load more
Mats Jerkeman

EHA 2025: Signs of Functional Cure for MCL in 25 Years Nordic Follow-Up Study

/ Mats Jerkeman
EHA25Lymfom Play the Video
Chan Cheah

EHA 2025: Sonrotoclax + Zanubrutinib Show Durable Responses in R/R CLL/SLL

/ Chan Cheah
CLLEHA25 Play the Video
Paolo Ghia

EHA 2025: Zanubrutinib Effective as First-Line CLL/SLL Therapy Regardless of del(17p)

/ Paolo Ghia
CLLEHA25 Play the Video
Ioannis Zerdes

Multidimensional Profiling of Immune Micro- and Macro-Environment in Early Breast Cancer Treated with Neoadjuvant Therapy

/ Ioannis Zerdes
BröstcancerNBCN Play the Video
Irma Frederiksson & Tove Filtenborg Tvedskov

Clinical Controversies in Axillary Management in Breast Cancer

/ Irma Frederiksson / Tove Holst Filtenborg Tvedskov
BröstcancerNBCN Play the Video
Tobias Berg

Increased Need for Improvement in the Treatment of Non-Luminal A Subtype Metastatic Breast Cancer in First-Line Treatment

/ Tobias Berg
BröstcancerNBCN Play the Video
Kristine Wiborg Høgsbjerg

Boost vs Surgery: Breast Induration Risk

/ Kristine Wiborg Høgsbjerg
Bröstcancer Play the Video
Hanne Norseth

EHA 2025: TG01 Shows Promise in KRAS-Mutated Myeloma

/ Hanne Norseth
EHA25Myelom Play the Video
Anders Svenningsson

Chronic Inflammatory Demyelinating Polyneuropathy: Current Therapies and Emerging Horizons

/ Anders Svenningsson
CIDP Play the Video
Anders Svenningsson

Current Classification and Management Strategies in CIDP

/ Anders Svenningsson
CIDP Play the Video
Anne Louise Tølbøll Sørensen

EHA 2025: Nordic AML Group Explores Optimized Regimen for AML Patients

/ Anne Louise Tølbøll Sørensen
AMLEHA25 Play the Video
Frida Bugge Askeland

EHA 2025: Impact of Treating MRD Relapse Post 1L in Multiple Myeloma

/ Frida Bugge Askeland
EHA25Myelom Play the Video
Mer
Back to top